Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Statistics

Total Valuation

Jeonjinbio has a market cap or net worth of KRW 26.41 billion. The enterprise value is 21.03 billion.

Market Cap	26.41B
Enterprise Value	21.03B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 16.09% in one year.

Current Share Class	9.06M
Shares Outstanding	9.06M
Shares Change (YoY)	+16.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	n/a
Float	7.94M

Valuation Ratios

The trailing PE ratio is 27.61.

PE Ratio	27.61
Forward PE	n/a
PS Ratio	1.71
PB Ratio	1.52
P/TBV Ratio	1.52
P/FCF Ratio	21.03
P/OCF Ratio	12.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.29, with an EV/FCF ratio of 16.74.

EV / Earnings	21.98
EV / Sales	1.36
EV / EBITDA	16.29
EV / EBIT	44.53
EV / FCF	16.74

Financial Position

The company has a current ratio of 10.35

Current Ratio	10.35
Quick Ratio	8.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	47.43

Financial Efficiency

Return on equity (ROE) is 5.59% and return on invested capital (ROIC) is 1.70%.

Return on Equity (ROE)	5.59%
Return on Assets (ROA)	1.54%
Return on Invested Capital (ROIC)	1.70%
Return on Capital Employed (ROCE)	2.69%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.81
Inventory Turnover	6.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.23% in the last 52 weeks. The beta is -0.66, so Jeonjinbio's price volatility has been lower than the market average.

Beta (5Y)	-0.66
52-Week Price Change	+25.23%
50-Day Moving Average	2,949.10
200-Day Moving Average	2,959.88
Relative Strength Index (RSI)	49.55
Average Volume (20 Days)	33,076

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeonjinbio had revenue of KRW 15.45 billion and earned 956.41 million in profits. Earnings per share was 105.58.

Revenue	15.45B
Gross Profit	4.47B
Operating Income	472.15M
Pretax Income	956.41M
Net Income	956.41M
EBITDA	1.29B
EBIT	472.15M
Earnings Per Share (EPS)	105.58

Balance Sheet

The company has 5.38 billion in cash and n/a in debt, giving a net cash position of 5.38 billion or 593.86 per share.

Cash & Cash Equivalents	5.38B
Total Debt	n/a
Net Cash	5.38B
Net Cash Per Share	593.86
Equity (Book Value)	17.38B
Book Value Per Share	1,918.92
Working Capital	8.24B

Cash Flow

In the last 12 months, operating cash flow was 2.11 billion and capital expenditures -852.38 million, giving a free cash flow of 1.26 billion.

Operating Cash Flow	2.11B
Capital Expenditures	-852.38M
Free Cash Flow	1.26B
FCF Per Share	138.63

Margins

Gross margin is 28.91%, with operating and profit margins of 3.06% and 6.19%.

Gross Margin	28.91%
Operating Margin	3.06%
Pretax Margin	6.19%
Profit Margin	6.19%
EBITDA Margin	8.35%
EBIT Margin	3.06%
FCF Margin	8.13%

Dividends & Yields

Jeonjinbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.09%
Shareholder Yield	-16.09%
Earnings Yield	3.62%
FCF Yield	4.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeonjinbio has an Altman Z-Score of 13.72 and a Piotroski F-Score of 5.

Altman Z-Score	13.72
Piotroski F-Score	5